Our Customers
Products & Pipeline
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube
NHS
US Payers
next arrow
Back
Company news
All
2 Min Read

Prix Galien 2022 award winners announced

13 May 2022
By

Last night, ieso attended The Galien Foundation Prix Galien UK Forum and Awards Ceremony. We were proud to be shortlisted in the UK Best Digital Health Solution category.  

The Galien Foundation is the premier global institution dedicated to honouring innovators in life sciences and the Prix Galien awards are regarded as the equivalent of the Nobel Prize for the life sciences industry.

Our sincere congratulations go out Behold.ai, who won the UK Best Digital Health Solution category on the night with their red dot V2 Clinical Analysis Software. We’d also like to congratulate the winners in the other UK categories - Alnylam Pharmaceuticals and Moderna shared Best Biotechnology Product, with ONPATTRO and SPIKEVAX respectively, Novo Nordisk for Best Pharmaceutical Product with Rybelsus, and Cyted for Best Medical Technology with Cytosponge.

Thanks too to The Galien Foundation. Acknowledging research-driven innovation with these awards is an important driver to ensure the continuous improvement of healthcare in the UK and human health globally.

See the full list of winners here.

Acknowledging research-driven innovation ensures the continuous improvement of healthcare in the UK and human health globally. Congratulations to this year’s Prix Galien UK winners...

Read more

Combining AI and human support in mental health: a digital intervention with comparable effectiveness to human-delivered care
Research papers
2025

Researchers conducted a study with 299 UK participants to evaluate if the digital program was acceptable and engaging, and if it was safe & effective in improving symptoms of anxiety, worry or stress.

For our latest Team Spotlight interview, we spoke to Brendon Kelly who recently joined ieso as Head of US Business Development.
Company news
5 min read
19th March 2025

In this team spotlight interview, we spoke to Brendon Kelly about his role as Head of US Business Development.

Acceptability of a Conversational Agent-led Digital Program for Anxiety: A Mixed-Methods Study of Patient Perspectives
Research papers
2025

Researchers conducted a study to understand if patients who used the ieso Digital Program for anxiety found it acceptable, engaging, and usable.